Latest Ratings for DKNG Date Firm Action From To Mar 2022 Argus Research Downgrades Buy Hold Feb 2022 Citigroup Maintains Buy Feb 2022 Roth Capital Upgrades Sell Neutral View More Analyst Ratings for DKNG View the Latest Analyst Ratings read more
Latest Ratings for ARCC Date Firm Action From To Feb 2022 Raymond James Maintains Outperform Dec 2021 Janney Montgomery Scott Initiates Coverage On Buy Oct 2021 Raymond James Maintains Outperform View More Analyst Ratings for ARCC View the Latest Analyst Ratings read more
Latest Ratings for DFS Date Firm Action From To Feb 2022 Deutsche Bank Upgrades Hold Buy Feb 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Piper Sandler Upgrades Neutral Overweight View More Analyst Ratings for DFS View the Latest Analyst Ratings read more
Latest Ratings for EXP Date Firm Action From To Jan 2022 Northcoast Research Upgrades Neutral Buy Dec 2021 Loop Capital Downgrades Buy Hold Nov 2021 Stephens & Co. Maintains Overweight View More Analyst Ratings for EXP View the Latest Analyst Ratings read more
Latest Ratings for VIRT Date Firm Action From To Feb 2022 Rosenblatt Maintains Buy Nov 2021 Rosenblatt Maintains Buy Aug 2021 Morgan Stanley Maintains Underweight View More Analyst Ratings for VIRT View the Latest Analyst Ratings read more
Analyst maintains Buy on $RNG, lowers price target to $28 due to lower revenue projections for fiscal 2025 and 2026, but highlights new products and potential for $100M ARR in 2025. Latest Ratings for RNG Date Firm Action From To Feb 2022 Evercore ISI Group Maintains Outperform Feb 2022 JP Morgan Maintains Overweight Feb 2022…
